The genetic myelin disorders are a range of diseases that manifest with severe neurological problems, often from infancy. It has been postulated for some time that stem cells might be an effective treatment for these disorders, primarily as agents to restore dysfunctional or lost myelin. Stem cells, however, may offer a wider range of therapeutic potential, for instance as vehicles to replace abnormal enzymes or genes, or to provide trophic support for residual CNS tissue. This article will review several of the more common genetic myelin disorders and currently available therapies, including bone marrow transplantation for adrenoleukodystrophy. Specific stem cell subtypes and their relevance to potential therapeutic use will be discussed and stem cell transplantation in animal model studies will also be reviewed.

Keywords:

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

1 Bielschowsfy M, Henneberg R: Über familiare diffuse sklerose (leukodystrophia cerebri prgressiva hereditaria). J. Psychol. Neurol.36,131–181 (1928).
Google Scholar
2 Sakai N: Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment. Brain Dev.31(7),485–487 (2009).
MedlineGoogle Scholar
3 Moser HW, Mahmood A, Raymond GV: X-linked adrenoleukodystrophy. Nat. Clin. Pract. Neurol.3(3),140–151 (2007).▪▪ Thorough review of one of the most common genetic myelin disorders.
MedlineGoogle Scholar
4 Korenke GC, Fuchs S, Krasemann E et al.: Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype. Ann. Neurol.40(2),254–257 (1996).
Medline CASGoogle Scholar
5 Eichler F, Van Haren K: Immune response in leukodystrophies. Pediatr. Neurol.37(4),235–244 (2007).
MedlineGoogle Scholar
6 Moser HW, Moser AB, Naidu S, Bergin A: Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev. Neurosci.13(4–5),254–261 (1991).
Medline CASGoogle Scholar
7 Moser HW, Moser AB, Hollandsworth K, Brereton NH, Raymond GV: “Lorenzo’s oil” therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy. J. Mol. Neurosci.33(1),105–113 (2007).
Medline CASGoogle Scholar
8 Duffner PK, Jalal K, Carter RL: The Hunter’s Hope Krabbe family database. Pediatr. Neurol.40(1),13–18 (2009).
MedlineGoogle Scholar
9 Wenger DA, Rafi MA, Luzi P: Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum. Mutat.10(4),268–279 (1997).
Medline CASGoogle Scholar
10 Tunici P, Pellegatta S, Finocchiaro G: The potential of stem cells for the treatment of brain tumors and globoid cell leukodystrophy. Cytotechnology41(2–3),93–101 (2003).
MedlineGoogle Scholar
11 Escolar ML, Poe MD, Provenzale JM et al.: Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease. N. Engl. J. Med.352(20),2069–2081 (2005).
Medline CASGoogle Scholar
12 Poorthuis BJ, Wevers RA, Kleijer WJ et al.: The frequency of lysosomal storage diseases in The Netherlands. Hum. Genet.105(1–2),151–156 (1999).
Medline CASGoogle Scholar
13 Ozkara HA, Topcu M: Sphingolipidoses in Turkey. Brain Dev.26(6),363–366 (2004).
MedlineGoogle Scholar
14 Biffi A, Lucchini G, Rovelli A, Sessa M: Metachromatic leukodystrophy: an overview of current and prospective treatments. Bone Marrow Transplant.42(Suppl. 2),S2–S6 (2008).
MedlineGoogle Scholar
15 Norton WT, Poduslo SE: Biochemical studies of metachromatic leukodystrophy in three siblings. Acta Neuropathol.57(2–3),188–196 (1982).
Medline CASGoogle Scholar
16 Eng B, Nakamura LN, O’Reilly N et al.: Identification of nine novel arylsulfatase A (ARSA) gene mutations in patients with metachromatic leukodystrophy (MLD). Hum. Mutat.22(5),418–419 (2003).
MedlineGoogle Scholar
17 Faerber EN, Melvin J, Smergel EM: MRI appearances of metachromatic leukodystrophy. Pediatr. Radiol.29(9),669–672 (1999).
Medline CASGoogle Scholar
18 Willard HF, Riordan JR: Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. Science230(4728),940–942 (1985).
Medline CASGoogle Scholar
19 Greer JM, Lees MB: Myelin proteolipid protein – the first 50 years. Int. J. Biochem. Cell Biol.34(3),211–215 (2002).
Medline CASGoogle Scholar
20 Garbern JY: Pelizaeus–Merzbacher disease: genetic and cellular pathogenesis. Cell Mol. Life Sci.64(1),50–65 (2007).
Medline CASGoogle Scholar
21 Inoue K: PLP1-related inherited dysmyelinating disorders: Pelizaeus–Merzbacher disease and spastic paraplegia type 2. Neurogenetics6(1),1–16 (2005).
Medline CASGoogle Scholar
22 Saugier-Veber P, Munnich A, Bonneau D et al.: X-linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat. Genet.6(3),257–262 (1994).
Medline CASGoogle Scholar
23 Vallstedt A, Klos JM, Ericson J: Multiple dorsoventral origins of oligodendrocyte generation in the spinal cord and hindbrain. Neuron45(1),55–67 (2005).
Medline CASGoogle Scholar
24 Mallon BS, Shick HE, Kidd GJ, Macklin WB: Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J. Neurosci.22(3),876–885 (2002).
Medline CASGoogle Scholar
25 Zhou Q, Anderson DJ: The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell109(1),61–73 (2002).
Medline CASGoogle Scholar
26 Cai J, Qi Y, Hu X et al.: Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and Shh signaling. Neuron45(1),41–53 (2005).
Medline CASGoogle Scholar
27 Spassky N, Olivier C, Perez-Villegas E et al.: Single or multiple oligodendroglial lineages: a controversy. Glia29(2),143–148 (2000).
Medline CASGoogle Scholar
28 Ben-Hur T, Goldman SA: Prospects of cell therapy for disorders of myelin. Ann. NY Acad. Sci.1142,218–249 (2008).
MedlineGoogle Scholar
29 Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, Alvarez-Buylla A: Origin of oligodendrocytes in the subventricular zone of the adult brain. J. Neurosci.26(30),7907–7918 (2006).
Medline CASGoogle Scholar
30 Nait-Oumesmar B, Decker L, Lachapelle F, Avellana-Adalid V, Bachelin C, Van Evercooren AB: Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur. J. Neurosci.11 (12),4357–4366 (1999).
Medline CASGoogle Scholar
31 Picard-Riera N, Decker L, Delarasse C et al.: Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc. Natl Acad. Sci. USA99(20),13211–13216 (2002).
Medline CASGoogle Scholar
32 De Marchis S, Fasolo A, Puche AC: Subventricular zone-derived neuronal progenitors migrate into the subcortical forebrain of postnatal mice. J. Comp. Neurol.476(3),290–300 (2004).
MedlineGoogle Scholar
33 Eriksson PS, Perfilieva E, Bjork-Eriksson T et al.: Neurogenesis in the adult human hippocampus. Nat. Med.4(11),1313–1317 (1998).
Medline CASGoogle Scholar
34 Roy NS, Wang S, Jiang L et al.: In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus. Nat. Med.6(3),271–277 (2000).
Medline CASGoogle Scholar
35 Bilican B, Fiore-Heriche C, Compston A, Allen ND, Chandran S: Induction of Olig2 precursors by FGF involves BMP signalling blockade at the Smad level. PLoS One3(8),e2863 (2008).
MedlineGoogle Scholar
36 Cheng X, Wang Y, He Q, Qiu M, Whittemore SR, Cao Q: Bone morphogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells. Stem Cells25(12),3204–3214 (2007).
Medline CASGoogle Scholar
37 Kessaris N, Jamen F, Rubin LL, Richardson WD: Cooperation between sonic hedgehog and fibroblast growth factor/MAPK signalling pathways in neocortical precursors. Development131(6),1289–1298 (2004).
Medline CASGoogle Scholar
38 Nicolay DJ, Doucette JR, Nazarali AJ: Transcriptional control of oligodendrogenesis. Glia55(13),1287–1299 (2007).
MedlineGoogle Scholar
39 Watanabe M, Hadzic T, Nishiyama A: Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination. Glia46(3),311–322 (2004).
MedlineGoogle Scholar
40 Fancy SP, Zhao C, Franklin RJ: Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol. Cell. Neurosci.27(3),247–254 (2004).
Medline CASGoogle Scholar
41 Sim FJ, Zhao C, Penderis J, Franklin RJ: The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J. Neurosci.22(7),2451–2459 (2002).
Medline CASGoogle Scholar
42 Redwine JM, Armstrong RC: In vivo proliferation of oligodendrocyte progenitors expressing PDGFαR during early remyelination. J. Neurobiol.37(3),413–428 (1998).
Medline CASGoogle Scholar
43 Dawson MR, Levine JM, Reynolds R: NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors? J. Neurosci. Res.61(5),471–479 (2000).
Medline CASGoogle Scholar
44 Levine JM, Reynolds R: Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Exp. Neurol.160(2),333–347 (1999).
Medline CASGoogle Scholar
45 Dawson MR, Polito A, Levine JM, Reynolds R: NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol. Cell. Neurosci.24(2),476–488 (2003).
Medline CASGoogle Scholar
46 Heins N, Lindahl A, Karlsson U et al.: Clonal derivation and characterization of human embryonic stem cell lines. J. Biotechnol.122(4),511–520 (2006).
Medline CASGoogle Scholar
47 Heins N, Englund MC, Sjoblom C et al.: Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells22(3),367–376 (2004).
MedlineGoogle Scholar
48 Billon N, Jolicoeur C, Ying QL, Smith A, Raff M: Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J. Cell Sci.115(Pt 18),3657–3665 (2002).
Medline CASGoogle Scholar
49 Reubinoff BE, Itsykson P, Turetsky T et al.: Neural progenitors from human embryonic stem cells. Nat. Biotechnol.19(12),1134–1140 (2001).
Medline CASGoogle Scholar
50 Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA: In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol.19(12),1129–1133 (2001).
Medline CASGoogle Scholar
51 Ben-Hur T, Idelson M, Khaner H et al.: Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells22(7),1246–1255 (2004).
MedlineGoogle Scholar
52 Chiba S, Iwasaki Y, Sekino H, Suzuki N: Transplantation of motoneuron-enriched neural cells derived from mouse embryonic stem cells improves motor function of hemiplegic mice. Cell Transplant.12(5),457–468 (2003).
MedlineGoogle Scholar
53 Keirstead HS, Nistor G, Bernal G et al.: Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci.25(19),4694–4705 (2005).
Medline CASGoogle Scholar
54 Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS: Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia49(3),385–396 (2005).
MedlineGoogle Scholar
55 Liu S, Qu Y, Stewart TJ et al.: Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc. Natl Acad. Sci. USA97(11),6126–6131 (2000).
Medline CASGoogle Scholar
56 Lee H, Shamy GA, Elkabetz Y et al.: Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells25(8),1931–1939 (2007).
Medline CASGoogle Scholar
57 Brustle O, Jones KN, Learish RD et al.: Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science285(5428),754–756 (1999).
Medline CASGoogle Scholar
58 Perez-Bouza A, Glaser T, Brustle O: ES cell-derived glial precursors contribute to remyelination in acutely demyelinated spinal cord lesions. Brain Pathol.15(3),208–216 (2005).
MedlineGoogle Scholar
59 Zhang YW, Denham J, Thies RS: Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Dev.15(6),943–952 (2006).
Medline CASGoogle Scholar
60 Pluchino S, Zanotti L, Rossi B et al.: Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature436(7048),266–271 (2005).
Medline CASGoogle Scholar
61 Lu P, Jones LL, Snyder EY, Tuszynski MH: Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol.181(2),115–129 (2003).
Medline CASGoogle Scholar
62 Kawabata K, Migita M, Mochizuki H et al.: Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres. Brain Res.1094(1),13–23 (2006).
Medline CASGoogle Scholar
63 Lacorazza HD, Flax JD, Snyder EY, Jendoubi M: Expression of human β-hexosaminidase α-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Nat. Med.2(4),424–429 (1996).
Medline CASGoogle Scholar
64 Klein D, Schmandt T, Muth-Kohne E et al.: Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy. Gene Ther.13(24),1686–1695 (2006).
Medline CASGoogle Scholar
65 Hentze H, Soong PL, Wang ST, Phillips BW, Putti TC, Dunn NR: Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res. (2009).
MedlineGoogle Scholar
66 Cao F, van der Bogt KE, Sadrzadeh A et al.: Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev.16(6),883–891 (2007).
Medline CASGoogle Scholar
67 Blum B, Benvenisty N: The tumorigenicity of human embryonic stem cells. Adv. Cancer Res.100,133–158 (2008).
MedlineGoogle Scholar
68 Bjorklund LM, Sanchez-Pernaute R, Chung S et al.: Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl Acad. Sci. USA99(4),2344–2349 (2002).
Medline CASGoogle Scholar
69 Li L, Baroja ML, Majumdar A et al.: Human embryonic stem cells possess immune-privileged properties. Stem Cells22(4),448–456 (2004).
Medline CASGoogle Scholar
70 Grinnemo KH, Kumagai-Braesch M, Mansson-Broberg A et al.: Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod. Biomed. Online13(5),712–724 (2006).
Medline CASGoogle Scholar
71 Nunes MC, Roy NS, Keyoung HM et al.: Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat. Med.9(4),439–447 (2003).
Medline CASGoogle Scholar
72 Eftekharpour E, Karimi-Abdolrezaee S, Wang J, El Beheiry H, Morshead C, Fehlings MG: Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction. J. Neurosci.27(13),3416–3428 (2007).▪ Demonstrates that adult neural progenitor cell transplantation can result in functionally significant myelination in the CNS.
Medline CASGoogle Scholar
73 Windrem MS, Roy NS, Wang J et al.: Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain. J. Neurosci. Res.69(6),966–975 (2002).
Medline CASGoogle Scholar
74 Windrem MS, Nunes MC, Rashbaum WK et al.: Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat. Med.10(1),93–97 (2004).
Medline CASGoogle Scholar
75 Svensson M, Wallstedt L, Janson AM, Frisen J: Neural stem cells in the adult human brain. Exp. Cell Res.253(2),733–736 (1999).
MedlineGoogle Scholar
76 Arsenijevic Y, Villemure JG, Brunet JF et al.: Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Exp. Neurol.170(1),48–62 (2001).
Medline CASGoogle Scholar
77 Kukekov VG, Laywell ED, Suslov O et al.: Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp. Neurol.156(2),333–344 (1999).
Medline CASGoogle Scholar
78 Dromard C, Guillon H, Rigau V et al.: Adult human spinal cord harbors neural precursor cells that generate neurons and glial cells in vitro. J. Neurosci. Res.86(9),1916–1926 (2008).
Medline CASGoogle Scholar
79 Mothe AJ, Tator CH: Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination. Exp. Neurol.213(1),176–190 (2008).
Medline CASGoogle Scholar
80 Mothe AJ, Kulbatski I, Parr A, Mohareb M, Tator CH: Adult spinal cord stem/progenitor cells transplanted as neurospheres preferentially differentiate into oligodendrocytes in the adult rat spinal cord. Cell Transplant.17(7),735–751 (2008).
MedlineGoogle Scholar
81 Rietze RL, Reynolds BA: Neural stem cell isolation and characterization. Methods Enzymol.419,3–23 (2006).
Medline CASGoogle Scholar
82 Pluchino S, Quattrini A, Brambilla E et al.: Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature422(6933),688–694 (2003).
Medline CASGoogle Scholar
83 Gensert JM, Goldman JE: Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron19(1),197–203 (1997).
Medline CASGoogle Scholar
84 Marshall GP 2nd, Laywell ED, Zheng T, Steindler DA, Scott EW: In vitro-derived “neural stem cells” function as neural progenitors without the capacity for self-renewal. Stem Cells24(3),731–738 (2006).
Medline CASGoogle Scholar
85 Dexter TM, Spooncer E: Growth and differentiation in the hemopoietic system. Annu. Rev. Cell Biol.3,423–441 (1987).
Medline CASGoogle Scholar
86 Kobari L, Giarratana MC, Pflumio F, Izac B, Coulombel L, Douay L: CD133⁺ cell selection is an alternative to CD34⁺ cell selection for ex vivo expansion of hematopoietic stem cells. J. Hematother. Stem Cell Res.10(2),273–281 (2001).
Medline CASGoogle Scholar
87 Rice CM, Scolding NJ: Adult stem cells for the treatment of neurological disease. Methods Mol. Biol.549,17–32 (2009).
Medline CASGoogle Scholar
88 Lim ZY, Ho AY, Abrahams S et al.: Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease. Bone Marrow Transplant.41(9),831–832 (2008).
Medline CASGoogle Scholar
89 Krivit W, Shapiro EG, Peters C et al.: Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N. Engl. J. Med.338(16),1119–1126 (1998).
Medline CASGoogle Scholar
90 Pierson TM, Bonnemann CG, Finkel RS, Bunin N, Tennekoon GI: Umbilical cord blood transplantation for juvenile metachromatic leukodystrophy. Ann. Neurol.64(5),583–587 (2008).
MedlineGoogle Scholar
91 Krivit W: Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Springer Semin. Immunopathol.26(1–2),119–132 (2004).
MedlineGoogle Scholar
92 Tokimasa S, Ohta H, Takizawa S et al.: Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: single-institute experience. Pediatr. Transplant.12(6),672–676 (2008).
Medline CASGoogle Scholar
93 Orchard PJ, Blazar BR, Wagner J, Charnas L, Krivit W, Tolar J: Hematopoietic cell therapy for metabolic disease. J. Pediatr.151(4),340–346 (2007).
MedlineGoogle Scholar
94 Gorg M, Wilck W, Granitzny B et al.: Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantation: a 13-year follow-up. J. Child Neurol.22(9),1139–1142 (2007).
MedlineGoogle Scholar
95 Boelens JJ: Trends in haematopoietic cell transplantation for inborn errors of metabolism. J. Inherit. Metab. Dis.29(2–3),413–420 (2006).
MedlineGoogle Scholar
96 Koshizuka S, Okada S, Okawa A et al.: Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice. J. Neuropathol. Exp. Neurol.63(1),64–72 (2004).
MedlineGoogle Scholar
97 Koda M, Okada S, Nakayama T et al.: Hematopoietic stem cell and marrow stromal cell for spinal cord injury in mice. Neuroreport16(16),1763–1767 (2005).
MedlineGoogle Scholar
98 Zhao ZM, Li HJ, Liu HY et al.: Intraspinal transplantation of CD34⁺ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. Cell Transplant.13(2),113–122 (2004).
MedlineGoogle Scholar
99 Nishio Y, Koda M, Kamada T et al.: The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats. J. Neurosurg. Spine5(5),424–433 (2006).
MedlineGoogle Scholar
100 Wagers AJ, Sherwood RI, Christensen JL, Weissman IL: Little evidence for developmental plasticity of adult hematopoietic stem cells. Science297(5590),2256–2259 (2002).
Medline CASGoogle Scholar
101 Herzog EL, Chai L, Krause DS: Plasticity of marrow-derived stem cells. Blood102(10),3483–3493 (2003).
Medline CASGoogle Scholar
102 Ying QL, Nichols J, Evans EP, Smith AG: Changing potency by spontaneous fusion. Nature416(6880),545–548 (2002).
Medline CASGoogle Scholar
103 Terada N, Hamazaki T, Oka M et al.: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature416(6880),542–545 (2002).
Medline CASGoogle Scholar
104 Johansson CB, Youssef S, Koleckar K et al.: Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat. Cell Biol.10(5),575–583 (2008).▪ Demonstration that fusion between rodent hematopoietic stem cells and rodent Purkinje cells can occur at increased levels in the context of CNS or systemic inflammation.
Medline CASGoogle Scholar
105 Nygren JM, Liuba K, Breitbach M et al.: Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat. Cell Biol.10(5),584–592 (2008).
Medline CASGoogle Scholar
106 Weimann JM, Trejo A, Blau HM: Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplantation Nat. Cell Biol.5(11),959–966 (2003).
Medline CASGoogle Scholar
107 Rice CM, Scolding NJ: Adult stem cells – reprogramming neurological repair? Lancet364(9429),193–199 (2004).
Medline CASGoogle Scholar
108 Mahmood A, Raymond GV, Dubey P, Peters C, Moser HW: Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study. Lancet Neurol.6(8),687–692 (2007).▪▪ Comparison study to ensure that the survival benefit seen with hematopoietic cell transplantation in childhood cerebral X-linked adrenoleukodystrophy was caused by hematopoietic cell transplantation and not just a favorable prognosis associated with that subgroup of adrenoleukodystrophy.
MedlineGoogle Scholar
109 Hickey WF, Kimura H: Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science239(4837),290–292 (1988).
Medline CASGoogle Scholar
110 Unger ER, Sung JH, Manivel JC, Chenggis ML, Blazar BR, Krivit W: Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study. J. Neuropathol. Exp. Neurol.52(5),460–470 (1993).▪ Demonstrates that donor marrow-derived cells can cross the blood–brain barrier and enter the brain.
Medline CASGoogle Scholar
111 Ito M, Blumberg BM, Mock DJ et al.: Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J. Neuropathol. Exp. Neurol.60(10),1004–1019 (2001).
Medline CASGoogle Scholar
112 Schonberger S, Roerig P, Schneider DT, Reifenberger G, Gobel U, Gartner J: Genotype and protein expression after bone marrow transplantation for adrenoleukodystrophy. Arch. Neurol.64(5),651–657 (2007).
MedlineGoogle Scholar
113 Aubourg P, Blanche S, Jambaque I et al.: Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N. Engl. J. Med.322(26),1860–1866 (1990).
Medline CASGoogle Scholar
114 Shapiro E, Krivit W, Lockman L et al.: Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet356(9231),713–718 (2000).
Medline CASGoogle Scholar
115 Peters C, Charnas LR, Tan Y et al.: Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood104(3),881–888 (2004).
Medline CASGoogle Scholar
116 Pittenger MF, Mackay AM, Beck SC et al.: Multilineage potential of adult human mesenchymal stem cells. Science284(5411),143–147 (1999).
Medline CASGoogle Scholar
117 Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM: Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood98(8),2396–2402 (2001).
Medline CASGoogle Scholar
118 Erices A, Conget P, Minguell JJ: Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol.109(1),235–242 (2000).
Medline CASGoogle Scholar
119 Prockop DJ, Marrow stromal cells as stem cells for nonhematopoietic tissues. Science276(5309),71–74 (1997).
Medline CASGoogle Scholar
120 Zvaifler NJ, Marinova-Mutafchieva L, Adams G et al.: Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res.2(6),477–488 (2000).
Medline CASGoogle Scholar
121 O’Donoghue K, Choolani M, Chan J et al.: Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol. Hum. Reprod.9(8),497–502 (2003).
MedlineGoogle Scholar
122 Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH: Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood103(5),1669–1675 (2004).
Medline CASGoogle Scholar
123 Suva D, Garavaglia G, J. Menetrey et al.: Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells. J. Cell. Physiol.198(1),110–118 (2004).
Medline CASGoogle Scholar
124 In’t Anker PS, Noort WA, Scherjon SA et al.: Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica88(8),845–852 (2003).
MedlineGoogle Scholar
125 Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ: Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol.107(2),275–281 (1999).
Medline CASGoogle Scholar
126 Colter DC, Class R, DiGirolamo CM, Prockop DJ: Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc. Natl Acad. Sci. USA97(7),3213–3218 (2000).
Medline CASGoogle Scholar
127 Javazon EH, Colter DC, Schwarz EJ, Prockop DJ: Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. Stem Cells19(3),219–225 (2001).
Medline CASGoogle Scholar
128 Haynesworth SE, Baber MA, Caplan AI: Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone13(1),69–80 (1992).
Medline CASGoogle Scholar
129 Woodbury D, Schwarz EJ, Prockop DJ, Black IB: Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res.61(4),364–370 (2000).
Medline CASGoogle Scholar
130 Galotto M, Berisso G, Delfino L et al.: Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp. Hematol.27(9),1460–1466 (1999).
Medline CASGoogle Scholar
131 Wakitani S, Saito T, Caplan AI: Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve18(12),1417–1426 (1995).
Medline CASGoogle Scholar
132 Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC: Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol.174(1),11–20 (2002).
MedlineGoogle Scholar
133 Woodbury D, Reynolds K, Black IB: Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J. Neurosci. Res.69(6),908–917 (2002).
Medline CASGoogle Scholar
134 Beyer Nardi N, da Silva Meirelles L: Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb. Exp. Pharmacol.174,249–282 (2006).
Google Scholar
135 Weimann JM, Charlton CA, Brazelton TR, Hackman RC, Blau HM: Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc. Natl Acad. Sci. USA100(4),2088–2093 (2003).▪▪ First demonstration that human adult bone marrow can contribute to cells in the adult human brain after transplantation.
Medline CASGoogle Scholar
136 Kennea NL, Waddington SN, Chan J et al.: Differentiation of human fetal mesenchymal stem cells into cells with an oligodendrocyte phenotype. Cell Cycle8(7),1069–1079 (2009).
Medline CASGoogle Scholar
137 Black IB, Woodbury D: Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cells Mol. Dis.27(3),632–636 (2001).
Medline CASGoogle Scholar
138 Yang J, Lou Q, Huang R, Shen L, Chen Z: Dorsal root ganglion neurons induce transdifferentiation of mesenchymal stem cells along a Schwann cell lineage. Neurosci. Lett.445(3),246–251 (2008).
Medline CASGoogle Scholar
139 Keilhoff G, Stang F, Goihl A, Wolf G, Fansa H: Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination. Cell Mol. Neurobiol.26(7–8),1235–1252 (2006).
MedlineGoogle Scholar
140 Keilhoff G, Goihl A, Langnase K, Fansa H, Wolf G: Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells. Eur. J. Cell Biol.85(1),11–24 (2006).
Medline CASGoogle Scholar
141 Mahay D, Terenghi G, Shawcross SG: Growth factors in mesenchymal stem cells following glial-cell differentiation. Biotechnol. Appl. Biochem.51(Pt 4),167–176 (2008).
Medline CASGoogle Scholar
142 Bossolasco P, Cova L, Calzarossa C et al.: Neuro-glial differentiation of human bone marrow stem cells in vitro. Exp. Neurol.193(2),312–325 (2005).
Medline CASGoogle Scholar
143 Fu L, Zhu L, Huang Y, Lee TD, Forman SJ, Shih CC: Derivation of neural stem cells from mesenchymal stemcells: evidence for a bipotential stem cell population. Stem Cells Dev.17(6),1109–1121 (2008).
Medline CASGoogle Scholar
144 Magrassi L, Grimaldi P, Ibatici A et al.: Induction and survival of binucleated Purkinje neurons by selective damage and aging. J. Neurosci.27(37),9885–9892 (2007).
Medline CASGoogle Scholar
145 Priller J, Persons DA, Klett FF, Kempermann G, Kreutzberg GW, Dirnagl U: Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo. J. Cell. Biol.155(5),733–738 (2001).
Medline CASGoogle Scholar
146 Bae JS, Han HS, Youn DH et al.: Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration. Stem Cells25(5),1307–1316 (2007).
Medline CASGoogle Scholar
147 Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N: Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res. (2009) (Epub ahead of print).
MedlineGoogle Scholar
148 Arnhold S, Klein H, Klinz FJ et al.: Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system. Eur. J. Cell Biol.85(6),551–565 (2006).
Medline CASGoogle Scholar
149 Hokari M, Kuroda S, Shichinohe H, Yano S, Hida K, Iwasaki Y: Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms. J. Neurosci. Res.86(5),1024–1035 (2008).
Medline CASGoogle Scholar
150 Parr AM, Tator CH, Keating A: Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant.40(7),609–619 (2007).
Medline CASGoogle Scholar
151 Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG: Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp. Neurol.198(1),54–64 (2006).
Medline CASGoogle Scholar
152 Zhao CP, Zhang C, Zhou SN et al.: Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice. Cytotherapy9(5),414–426 (2007).
Medline CASGoogle Scholar
153 Himes BT, Neuhuber B, Coleman C et al.: Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil. Neural Repair20(2),278–296 (2006).
MedlineGoogle Scholar
154 Zhang J, Li Y, Chen J et al.: Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res.1030(1),19–27 (2004).
Medline CASGoogle Scholar
155 Zhang J, Li Y, Lu M et al.: Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J. Neurosci. Res.84(3),587–595 (2006).
Medline CASGoogle Scholar
156 Gordon D, Pavlovska G, Glover CP, Uney JB, Wraith D, Scolding NJ: Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration. Neurosci. Lett.448(1),71–73 (2008).
Medline CASGoogle Scholar
157 Chopp M, Zhang XH, Li Y et al.: Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport11(13),3001–3005 (2000).
Medline CASGoogle Scholar
158 Lee J, Kuroda S, Shichinohe H et al.: Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology23(3),169–180 (2003).
MedlineGoogle Scholar
159 Croitoru-Lamoury J, Williams KR, Lamoury FM et al.: Neural transplantation of human MSC and NT2 cells in the twitcher mouse model. Cytotherapy8(5),445–458 (2006).
Medline CASGoogle Scholar
160 Akiyama Y, Radtke C, Kocsis JD: Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J. Neurosci.22(15),6623–6630 (2002).
Medline CASGoogle Scholar
161 Akiyama Y, Radtke C, Honmou O, Kocsis JD: Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia39(3),229–236 (2002).
MedlineGoogle Scholar
162 Chopp M, Li Y: Treatment of neural injury with marrow stromal cells. Lancet Neurol.1(2),92–100 (2002).
MedlineGoogle Scholar
163 Mahmood A, Lu D, Lu M, Chopp M: Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery53(3),697–702; discussion 702–703 (2003).
MedlineGoogle Scholar
164 Mahmood A, Lu D, Qu C, Goussev A, Chopp M: Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats. Neurosurgery57(5),1026–1031; discussion 1026–1031 (2005).
MedlineGoogle Scholar
165 Bang OY, Lee JS, Lee PH, Lee G: Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol.57(6),874–882 (2005).
MedlineGoogle Scholar
166 Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K: Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin. Pharmacol. Ther.83(5),723–730 (2008).
Medline CASGoogle Scholar
167 Mazzini L, Ferrero I, Luparello V et al.: Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a Phase I clinical trial. Exp. Neurol.223(1),229–237 (2010).
Medline CASGoogle Scholar
168 Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W: Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant.30(4),215–222 (2002).
Medline CASGoogle Scholar
169 Scolding N, Marks D, Rice C: Autologous mesenchymal bone marrow stem cells: practical considerations. J. Neurol. Sci.265(1–2),111–115 (2008).
Medline CASGoogle Scholar
170 Bartholomew A, Sturgeon C, Siatskas M et al.: Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol.30(1),42–48 (2002).
MedlineGoogle Scholar
171 Beyth S, Borovsky Z, Mevorach D et al.: Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood105(5),2214–2219 (2005).
Medline CASGoogle Scholar
172 Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O: HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol.31(10),890–896 (2003).
Medline CASGoogle Scholar
173 Maitra B, Szekely E, Gjini K et al.: Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant.33(6),597–604 (2004).
Medline CASGoogle Scholar
174 Kim YJ, Park HJ, Lee G et al.: Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia57(1),13–23 (2009).
MedlineGoogle Scholar
175 Zhou C, Zhang C, Chi S et al.: Effects of human marrow stromal cells on activation of microglial cells and production of inflammatory factors induced by lipopolysaccharide. Brain Res.1269,23–30 (2009).
Medline CASGoogle Scholar
176 Bae JS, Furuya S, Ahn SJ, Yi SJ, Hirabayashi Y, Jin HK: Neuroglial activation in Niemann-Pick Type C mice is suppressed by intracerebral transplantation of bone marrow-derived mesenchymal stem cells. Neurosci. Lett.381(3),234–236 (2005).
Medline CASGoogle Scholar
177 Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4),663–676 (2006).▪▪ Discovers that pluripotent stem cells can be directly generated from lineage-restricted cells.
Medline CASGoogle Scholar
178 Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science318(5858),1917–1920 (2007).
Medline CASGoogle Scholar
179 Dimos JT, Rodolfa KT, Niakan KK et al.: Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science321(5893),1218–1221 (2008).
Medline CASGoogle Scholar
180 Park IH, Arora N, Huo H et al.: Disease-specific induced pluripotent stem cells. Cell134(5),877–886 (2008).
Medline CASGoogle Scholar
181 Soldner F, Hockemeyer D, Beard C et al.: Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell136(5),964–977 (2009).
Medline CASGoogle Scholar
182 Chamberlain SJ, Li XJ, Lalande M: Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders. Neurogenetics9(4),227–235 (2008).
MedlineGoogle Scholar
183 Karumbayaram S, Novitch BG, Patterson M et al.: Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells27(4),806–811 (2009).
Medline CASGoogle Scholar
184 Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131(5),861–872 (2007).
Medline CASGoogle Scholar
185 Nakagawa M, Koyanagi M, Tanabe K et al.: Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol.26(1),101–106 (2008).
Medline CASGoogle Scholar
186 Mali P, Ye Z, Hommond HH et al.: Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells26(8),1998–2005 (2008).
Medline CASGoogle Scholar
187 Wernig M, Zhao JP, Pruszak J et al.: Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc. Natl Acad. Sci. USA105(15),5856–5861 (2008).
Medline CASGoogle Scholar
188 Hanna J, Wernig M, Markoulaki S et al.: Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science318(5858),1920–1923 (2007).
Medline CASGoogle Scholar
189 Yandava BD, Billinghurst LL, Snyder EY: “Global” cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc. Natl Acad. Sci. USA96(12),7029–7034 (1999).
Medline CASGoogle Scholar
190 Windrem MS, Schanz SJ, Guo M et al.: Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell2(6),553–565 (2008).
Medline CASGoogle Scholar
191 Low HP, Greco B, Tanahashi Y et al.: Embryonic stem cell rescue of tremor and ataxia in myelin-deficient shiverer mice. J. Neurol. Sci.276(1–2),133–137 (2009).
MedlineGoogle Scholar
192 Dautigny A, Mattei MG, Morello D et al.: The structural gene coding for myelin-associated proteolipid protein is mutated in jimpy mice. Nature321(6073),867–869 (1986).
Medline CASGoogle Scholar
193 Duncan ID: The PLP mutants from mouse to man. J. Neurol. Sci.228(2),204–205 (2005).
Medline CASGoogle Scholar
194 Klugmann M, Schwab MH, Puhlhofer A et al.: Assembly of CNS myelin in the absence of proteolipid protein. Neuron18(1),59–70 (1997).
Medline CASGoogle Scholar
195 Tontsch U, Archer DR, Dubois-Dalcq M, Duncan ID: Transplantation of an oligodendrocyte cell line leading to extensive myelination. Proc. Natl Acad. Sci. USA91(24),11616–11620 (1994).
Medline CASGoogle Scholar
196 Espinosa de los Monteros A, Zhao P, Huang C et al.: Transplantation of CG4 oligodendrocyte progenitor cells in the myelin-deficient rat brain results in myelination of axons and enhanced oligodendroglial markers. J. Neurosci. Res.50(5),872–887 (1997).
Medline CASGoogle Scholar
197 Lu JF, Lawler AM, Watkins PA et al.: A mouse model for X-linked adrenoleukodystrophy. Proc. Natl Acad. Sci. USA94(17),9366–9371 (1997).
Medline CASGoogle Scholar
198 Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL: Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum. Mol. Genet.11(5),499–505 (2002).
Medline CASGoogle Scholar
199 Pujol A, Ferrer I, Camps C et al.: Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum. Mol. Genet.13(23),2997–3006 (2004).
Medline CASGoogle Scholar
200 Ferrer I, Kapfhammer JP, Hindelang C et al.: Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage. Hum. Mol. Genet.14(23),3565–3577 (2005).
Medline CASGoogle Scholar
201 Mastroeni R, Bensadoun JC, Charvin D, Aebischer P, Pujol A, Raoul C: Insulin-like growth factor-1 and neurotrophin-3 gene therapy prevents motor decline in an X-linked adrenoleukodystrophy mouse model. Ann. Neurol.66(1),117–122 (2009).
MedlineGoogle Scholar
202 Kassmann CM, Lappe-Siefke C, Baes M et al.: Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet.39(8),969–976 (2007).
Medline CASGoogle Scholar
203 Lappe-Siefke C, Goebbels S, Gravel M et al.: Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet.33(3),366–374 (2003).
Medline CASGoogle Scholar
204 Irvine KA, Blakemore WF: Remyelination protects axons from demyelination-associated axon degeneration. Brain131(Pt 6),1464–1477 (2008).
Medline CASGoogle Scholar
205 Kaye EM: Update on genetic disorders affecting white matter. Pedriat. Neurol.24,11–24 (2001).
Medline CASGoogle Scholar
301 X-linked Adrenoleukodystrophy Database www.x-ald.nl
Google Scholar

Vol. 5, No. 3

Metrics

Downloaded 178 times

History

Published online 10 May 2010

Published in print May 2010

Information

Keywords

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

PDF download

Stem cells in genetic myelin disorders

Abstract

Bibliography